Crescent Biopharma, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to developing innovative protease therapeutics that target hemostasis and complement regulation. The company is poised to address significant unmet medical needs through its promising pipeline, which includes novel candidates designed to tackle serious conditions associated with blood coagulation and immune response. Leveraging advanced research and proprietary technologies, Crescent Biopharma aims to deliver transformative solutions within the biopharmaceutical sector, positioning itself as a key player in the evolving landscape of therapeutic advancements.
Click "Analyze" to generate stock analysis
CBIO Price Trend and Signals
CBIO Financials
2025-10-27Somewhat Bullishprice_signal
Monthly high detected.
2025-10-16Bullishmacd_signal
Golden cross below zero detected.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.